False
Farhad Hafezi is a Professor of Ophthalmology at the University of Geneva, Switzerland; Research Group Leader at the CABMM of the University of Zurich, Switzerland; Chief Medical Officer of the ELZA Institute, Zurich, Switzerland; Adjunct Clinical Professor of Ophthalmology at the USC Roski Eye Institute, Los Angeles, USA; Research Professor at the NYU Grossman School of Medicine, New York, and Visiting Professor at the Wenzhou Medical University, Wenzhou, China.
May 1, 2024
TransPRK, PACE, and All Femto CAIRS as surgical options for keratoconus
7 min read
June 28, 2023
A quick tour of the latest breakthroughs in keratoconus treatment
7 min read
May 26, 2020
From the podium to the webinar platform: providing access to learning for everyone
1 min read
August 27, 2019
What drives progress in medicine? Identifying and meeting unmet needs
1 min read
September 12, 2019
How should we persuade children – particularly those with communication challenges – to co-operate during ophthalmic examinations? Light for Sight’s new Procedure to Increase Compliance may hold the answer
1 min read
November 5, 2015
Swiss researchers have developed methods for performing corneal crosslinking with riboflavin and corneal biomechanical testing in mice – opening up the world of transgenics and molecular testing.
1 min read
May 19, 2014
The concept of using photoactivated chromophores for corneal cross-linking (PACK-CXL) as a weapon against infectious keratitis is compelling. The evidence suggests that PACK-CXL could have a dramatic impact on a major cause of global blindness… but only if the expensive, bulky technology (and the requirement for a corneal surgeon in a sterile operating theater) can be overcome. One company may have the answer.
1 min read
Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.
False